Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Med Vet International McKesson 10-Drug Panel with Adulterants Drugs of Abuse Test, 16-8105A3, 25/Box

Supplier:  Med Vet International 1101531BX

Encompass_Preferred

Drugs of Abuse Test McKesson 10-Drug Panel with Adulterants AMP, BUP, BZO, COC, mAMP/MET, MDMA, MTD, MOP300, OXY, THC (OX, pH, SG) Urine Sample 25 Tests CLIA Waived All-in-one preliminary screening test for the qualitative detection of multiple drugs and drug metabolites in urine at specific cut-off levels CLIA-waved urine drug screen Offers panel size up to 10 analytes with an additional three adulteration tests Tests simultaneously for the following drugs, consumption of which is prohibited by the Controlled Substances Act for amphetamine, benzodiazepines, buprenorphine, cocaine, marijuana, methamphetamine, ecstasy, opiates, methadone, oxycodone Rapid, visually read results in just 5 minutes Of the 10 analytes, specifically, this test cup provides screening for buprenorphine (BUP) and opiates (MOP300) at low-level cut offs Built-in specimen validity test (SVT) strip verifies the validity of the specimen to compare with the adulteration color comparison chart card (included)

Catalog No. 50-304-4718


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.